Home » Newsletters » BioWorld

BioWorld

Sep. 30, 1997

View Archived Issues

CDR Acquires CellGenEx; Renames Itself Xcyte Therapies

Ligand Says Phase II/III Positive For Oral Targretin In CTCL

Other News To Note

In Cases Of Extreme Obesity, Leptin Receptor Jumps Gun On Its Own Ligand Trigger

Coulter, Cell Therapeutics Seek Combined $57M In Offerings

Gilead's Oral Drug Blocks, Relieves Flu In Phase II Studies